Alliance for Clinical Trials in Oncology
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
- Conditions
- Colorectal Cancer
- Interventions
- First Posted Date
- 2003-09-25
- Last Posted Date
- 2020-04-29
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 1691
- Registration Number
- NCT00003594
- Locations
- 🇺🇸
Hematology Oncology Associates of Illinois - Lake Shore Dr, Chicago, Illinois, United States
🇺🇸Grady Memorial Hospital, Atlanta, Georgia, United States
🇺🇸Emory University Hospital - Atlanta, Atlanta, Georgia, United States
Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- First Posted Date
- 2003-09-24
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 84
- Registration Number
- NCT00003281
- Locations
- 🇺🇸
CCOP - Ochsner, New Orleans, Louisiana, United States
🇺🇸CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States
🇺🇸CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
- Conditions
- Psychosocial Effects of Cancer and Its TreatmentBreast Cancer
- Interventions
- Procedure: psychosocial assessment and careProcedure: quality-of-life assessment
- First Posted Date
- 2003-09-11
- Last Posted Date
- 2017-08-08
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 1706
- Registration Number
- NCT00068328
- Locations
- 🇺🇸
Elkhart Clinic, LLC, Elkhart, Indiana, United States
🇺🇸FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center, Pinehurst, North Carolina, United States
🇺🇸Elkhart General Hospital, Elkhart, Indiana, United States
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
- Conditions
- Melanoma (Skin)Metastatic Cancer
- Interventions
- Drug: temozolomideRadiation: radiation therapy
- First Posted Date
- 2003-09-11
- Last Posted Date
- 2016-12-15
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 41
- Registration Number
- NCT00068666
- Locations
- 🇺🇸
John Stoddard Cancer Center at Iowa Methodist Medical Center, Des Moines, Iowa, United States
🇺🇸Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
🇺🇸Mercy Capitol Hospital, Des Moines, Iowa, United States
Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
- Conditions
- NeurotoxicityPainUnspecified Adult Solid Tumor, Protocol Specific
- Interventions
- Other: PlaceboDrug: lamotrigine
- First Posted Date
- 2003-09-11
- Last Posted Date
- 2018-05-04
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 131
- Registration Number
- NCT00068445
- Locations
- 🇺🇸
Siouxland Hematology-Oncology Associates at June E. Nylen Cancer Center, Sioux City, Iowa, United States
🇺🇸Coborn Cancer Center, Saint Cloud, Minnesota, United States
🇺🇸Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
Lycopene in Treating Patients With Metastatic Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- Dietary Supplement: lycopene
- First Posted Date
- 2003-09-11
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 47
- Registration Number
- NCT00068731
- Locations
- 🇺🇸
CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale, Arizona, United States
🇺🇸CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States
🇺🇸CCOP - Upstate Carolina, Spartanburg, South Carolina, United States
Combination Chemotherapy in Treating Patients With Colorectal Cancer
- Conditions
- Colorectal Cancer
- Interventions
- First Posted Date
- 2003-09-03
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 400
- Registration Number
- NCT00006103
Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- First Posted Date
- 2003-09-03
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 60
- Registration Number
- NCT00006265
- Locations
- 🇺🇸
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse, New York, United States
🇺🇸Veterans Affairs Medical Center - Dallas, Dallas, Texas, United States
🇺🇸CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States
Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia
- Conditions
- Leukemia
- Interventions
- Genetic: reverse transcriptase-polymerase chain reaction
- First Posted Date
- 2003-08-20
- Last Posted Date
- 2016-07-04
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 9769
- Registration Number
- NCT00003931
- Locations
- 🇺🇸
University of California San Diego Cancer Center, La Jolla, California, United States
🇺🇸Mount Sinai Medical Center, NY, New York, New York, United States
🇺🇸CCOP - Christiana Care Health Services, Wilmington, Delaware, United States
Hormone Therapy in Treating Patients With Prostate Cancer
- Conditions
- Prostate CancerSexual Dysfunction and Infertility
- Interventions
- First Posted Date
- 2003-08-13
- Last Posted Date
- 2016-07-04
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 101
- Registration Number
- NCT00003323
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States
🇺🇸University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States